Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.05 USD | +1.21% | -2.75% | -10.94% |
May. 10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
May. 08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.94% | 1.4B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+12.96% | 238B | |
+6.94% | 204B | |
-6.50% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating